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One of us (F.R.)  recently reported a  method allowing for the long-term culture of 
normal human T lymphocytes from peripheral blood or bone marrow (1). Exponential 
proliferative  growth  was  dependent  upon  the  addition  of a  T-cell  growth  factor 
(TCGF)  produced  by phytohemagglutinin-stimulated  normal  human  lymphocytes 
(1, 2). We have used similar methodology and have reported the long-term culture of 
murine tumor-antigen specific cytotoxie T-cell lines (CTLL) (3).  Murine CTLL have 
remained in culture for over 20 mo during which time they have continued to mediate 
syngeneic tumor-specific cytotoxic reactivity. Both of the above mentioned observa- 
tions involving the continuous culture of normal human and differentiated murine 
CTLL have been confirmed (4, 5). 
We  now  report  the  ability  to  culture  large  numbers  of human  antigen-specific 
cytotoxic T  lymphocytes in a TCGF-dependent state of sustained exponential prolif- 
eration. This technological advance should allow for the performance of studies that 
were previously not possible, such  as the characterization  of cytotoxic T-cell differ- 
entiation  markers,  the  molecular  mechanism  of  lymphocyte-mediated  cytolysis 
(LMC), and the nature of the T-ceU antigen receptor. In addition, human (H)-CTLL 
may provide a new tool for the typing of cell surface antigens; as well as provide new 
insight  into  the  immunotherapeutic  manipulation  of several  disease  states,  most 
notably:  immunodeficiency, autoimmunity,  and the  host's response to malignancy. 
Materials and Methods 
In  Vitro Generation and Long-Term Culture of H-CTLL.  Antigen-specific  cytotoxic T cells were 
generated in 7 day primary or 10 day secondary one-way mixed lymphocyte culture (MLC). 
Both  responder and  stimulator lymphocyte populations were isolated from normal human 
peripheral blood by Ficoll-Hypaque sedimentation  (6)  and  diluted  to  1  ×  10  e eells/ml in 
RPMI-1640 supplemented with 10% heat-inactivated fetal calf serum, Grand Island Biological 
Co., Grand Island, N. Y., 300 #g/ml L-glutamine, 50 U/ml penicillin-G,  50 #g/ml gentamicin, 
and 25 #M/ml Hepes buffer (Calbiochem, San Diego, Calif.). Responding lymphoeytes (10 ml) 
were mixed with an equal volume of previously X-irradiated allogeneic  stimulator cells and 
cultured at 37°C in a humidified atmosphere of 5% COz in air. After 7 days viable responding 
lymphocytes were harvested and used as either effector cell  populations in 4 h  5XCr-release 
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assays  or placed into long-term culture.  H-CTLL were initiated  by culturing MLC effector 
cells in a solution containing 50% human TCGF and 50% supplemented RPMI-1640. 
LMCAssay.  H-CTLL were tested periodically for continued expression of  stimulator specific 
cytotoxicity as measured in a 4-h 5XCr-release assay.  Targets used were either freshly isolated 
peripheral blood mononuclear cells or long-term T-cell lines.  LMC assays were conducted as 
previously described (7). Percent specific lysis at varying effeetor/target cell ratios was calculated 
according to the following equation: 
experimental cpm -  medium control cpm 
percent specific lysis=-  100  × 
maximum release  cpm -- medium control cpm' 
Lyric reactivity was detailed in terms of both lytic capacity (LC) and lytic efficiency (LE). LC 
was defined  as the number of lytic units  (LU)/10  e CTLL cells.  1 LU was defined  as that 
number of effector cells required to mediate 30% specific lysis. LE was defined as the percent 
specific lysis observed at an effector/target cell ratio of 100/1. 
Co~opreservation.  H-CTLL were periodically  cryopreserved with  the  aid  of a  Planar  pro- 
grammed slow-freeze  apparatus  (Planar Co., Sunbury on Thames,  England).  Cultures were 
prepared for freezing by resuspension in FCS at 4°C and dilution over a 10-min period with an 
equal  volume of RPMI-1640 supplemented  with  20%  dimethylsulfoxide  and  0.2%  EDTA. 
Frozen human CTLL were maintained in the vapor phase of liquid nitrogen. 
Human CTLL Cell Surface Characterization.  H-CTLL were tested for their ability to rosette 
sheep erythrocytes by using methodology previously described (8). H-CTLL were also tested 
for the cell surface expression of  both human T-cell antigen and HLA-D or Ia-like determinants. 
5~Cr-labeled CTLL cells were used as target cells in antibody-dependent complement-mediated 
cytolysis assays  using absorbed rabbit complement, antigen-specific typing sera, and method- 
ology previously described  (7). Both anti-T-cell  antigen  (A54-5,  10-6) and  anti-Ia-like sera 
(7147-126) were provided by Dr. Jun Minowada, Roswell Park Memorial Institute, Buffalo, N. 
Y.  (9,  10). Positive  control  human  leukemia  cells  (MOLT-4F  and  DAUDI or  NALM-1, 
respectively)  were also provided by Dr. Minowada  (9-11). The cell  surface presence of these 
markers was expressed as the reciprocal of the highest antiserum dilution causing 20% specific 
lysis. 
Results 
Cytolytic  Reactivity  of H-CTLL.  H-CTLL-1  was  initiated  after  secondary  MLC 
stimulation  ((A  +  Bx)  +  Bx)  and  has  remained  in  continuous  TCGF-dependent 
culture  for 4  too.  The  continued  expression  of alloantigen-specific  cytolysis by  H- 
CTLL-1 is displayed in Fig.  1. Effector cell populations depicted include H-CTLL-1 
cells tested at the conclusion of MLC stimulation and after 6 and 12 wk of culture. H- 
CTLL-l-mediated,  alloantigen-directed  cytotoxicity remained  remarkably  constant 
over this 3 mo period. It is important to note that self or third-party target cells were 
not  affected  thereby  confirming  that  H-CTLL-l-mediated  cytolysis  was  antigen- 
specific. 
Data representing the long-term culture of two additional  H-CTLL  are shown in 
Table I. In this experimentation, effector cells were generated in primary 7 day MLC 
before culture  in TCGF-containing  medium.  The  result  of LMC  assays  conducted 
immediately after MLC and after 4 wk in culture are displayed both in terms of LC 
and  LE.  H-CTLL-2  (C  +  Bx)  cells  specifically  lysed  B  target  cells  (410  LU/106) 
effector cells after 4 wk in culture). Similarly H-CTLL-3 (B  +  Cx) cells were effective 
in mediating only the lysis of the allogeneic C  target cell. 
Co,  opreservation of H-CTLL.  The  ability  to  recover  cytolytic  T  cells  from  the 
cryopreserved state  would greatly  facilitate  many of the  potential  uses  of H-CTLL 
(e.g. tissue typing, immunotherapy).  Therefore, experiments were designed in which 
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FIG.  1.  Cytotoxic reactivity of H-CTLL-I cells. (A  +  B,)  +  B, secondary MLC effeetor-cell- 
mediated lysis of B target cell (1~----0),  atuologous A target cell (O  ©). 6 wk cultured H- 
CTLL-1 cell-mediated lysis of B target cell (A  A), third party C target cell, (A  A). 12 wk 
cultured H-CTLL-1 cell-mediated lysis of B  target cell (I------~,  autologous A  target cell 
(o  0). 
TABLE  I 
Cytolytic Specificity of H-CTLL 
Cytolytic  reactivity 
MLC  Target B  Target C  H-CTLL  Culture 
stimula- 
designation  tion  duration  Lytic  Lytic  Lytic  Lytic 
capac-  el'ft-  capac-  etll- 
ity*  ciency:~  ity  ciency 
wk 
H-CTLL-2  C  +  B,  0  368  73.9  0.1  1.5 
"  4  410  85  0.3  8.0 
H-CTLL-3  B  +  Cx  0  <0.1  < 1.0  25.0  33 
4  <0. i  < 1.0  28.5  38 
*  Expressed as LU/10 ~ CTLL cells, 
:~ Expre,x~d as percent specific lysis  observed at a CTLL/target cell ratio of 100/1. 
of liquid  nitrogen.  Upon  thawing,  frozen  CTLL  were  re-established  in  long-term 
TCGF-dependent  culture.  2  and 4  wk after reinitiation  of continuous culture, both 
previously  frozen  and  control  H-CTLL-1  cells  were  tested  for cytotoxic  reactivity 
directed against radiolabeled B  target cells. Results of these experiments are detailed 
in Table II. Both re-established and control cells demonstrated similar high levels of 
cytolytic reactivity against B  target cells. 
Cell Surface Characterization of H-CTLL.  H-CTLL  cells were found to be  lympho- 
blastoid  in  appearance  and  95-100%  E-rosette  positive.  Fig.  2  shows  a  cytospin 
preparation of E-rosette positive H-CTLL-1  cells after 11 wk of culture. We also tested 
H-CTLL-1 cells for the cell membrane expression of two surface markers via antibody- 
dependent complement-mediated cytolysis assays. The two typing sera used included 
anti-T-LCL  antiserum and anti-Ia-like antiserum. Anti-T-LCL  antiserum has previ- 
ously been shown to contain antibody against a  normal T-cell  antigen  (9).  Anti-Ia- 
like  antiserum  was  raised  in  rabbits  by  immunization  with  the  DAUDI  human 
lymphoblastoid cell line. The DAUDI cell membrane is void of HLA antigens A, B, 1096  GIIA.IS  ET  AL.  BRIEF  DEFINITIVE  REPORT 
ThatE II 
Stability of H-CTLL  Cytolytic Reactivity after 
Cryopreservation 
H-CTLL designation  Culture duration 
Cytotoxicity  directed 
against  B target 
Lyric  Lyric effi- 
capacity"  ciency~: 
wk 
H-CTLL- 1  4  118  58 
"  6  101  46 
"  8  98  42 
H-CTLL-I  (frozen  2 wk after  125  50 
4-wk old cultures)  thawing 
H-CTLL-I (frozen  4 wk after  112  51 
4-wk old cultures)  thawing 
* Expressed  as LU/106 CTLL cells. 
Expressed  as percent  specific  lysis observed  at a CTLL/target  cell 
ratio of I00/1. 
TABLE III 
H-CTLL  Cell Surface Characterization 
Target cell  line 
Antibody-dependent  comple- 
ment-mediated 
cytolysis  assay  data* 
Anti-T-cell  Anti-Ia-like 
antiserum~t  antiserum§ 
CTLL- 1  35  20 
DAUDI  [1  160 
MOLT-4F  40  [[ 
NALM- 1  [I  80 
* Expressed  as the reciprocal  of the highest antiserum  dilution  which 
caused 20% specific  lysis. 
Rabbit  anti-T-LCL antiserum  (Dr. Jun  Minowada,  Rosweil Park 
Memorial Institute,  Buffalo,  N.Y.). 
§ Rabbit anti-DAUDI-(HLA-D) antiserum  (Dr. Jun Minowada). 
][ No reactivity  observed. 
FIG.  2.  Cytospin  preparation  H-CTLL-I  E-rosettes.  Magnification  ~  ×  5,600. 
or C,  yet  does express  an  HLA-D  encoded glycoprotein  (10).  The  results of the cell 
surface characterization of H-CTLL-1  cells is detailed  in Table  III.  H-CTLL-1  cells 
were found to be positive for the surface expression of both normal T-cell and Ia-like 
antigens.  Control  cell  lines  DAUDI,  MOLT-4F,  and  NALM-1  were  found  to  be 
positive for the respective expression of previously detected cell surface markers (9-11). 
Discussion 
The ability to sustain antigen-specific human cytolytic T  lymphocytes in continuous 
proliferative culture provides a new technology for the study of cell-mediated immune 
responses. The cells retain characteristic T-cell surface markers and maintain stable, 
specific  cytolytic  activity  after  prolonged  culture  or reconstitution  from cryopreser- 
vation. Such cells will undoubtedly prove useful as tissue typing reagents,  for studies 
on the mechanism of LMC  and for characterization of T-cell  antigen receptors and 
T-cell surface markers. 
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development of monoclonal, antigen-specific CTLL. For example, a battery of cloned 
H-CTLL, each with a  specificity for individual HLA antigens would be invaluable 
for tissue-typing studies. We have recently been successful in cloning murine CTLL 
by limiting dilution in microplates. 1 Similar results have also been observed in cloning 
trials attempted on long-term normal human T-cell lines (F. R. Ruscetti, unpublished 
observations). Based on these observations it should be possible to develop monoclonal, 
unifunctional H-CTLL. 
One implication of the experimentation described in this report would be the use 
of tumor-antigen-specific H-CTLL cells  for the  immunotherapy of human malig- 
nancy. We have previously reported the long-term culture of murine tumor-antigen- 
specific CTLL (3).  Murine CTLL maintained in culture for over 20 mo have been 
found to significantly retard in vivo tumor growth in adoptive transfer experiments.  2 
These findings together with recent reports describing in vitro generation of human 
leukemia-specific cytotoxic cells ([through multi-way mixed tumor lymphocyte stim- 
ulation] [12,  13]) suggest that tumor-antigen reactive CTLL might be successful as a 
new form of specific immunotherapy. 
It is important to note that H-CTLL are thoroughly dependent for proliferation 
upon the presence of TCGF. TCGF deprivation results in H-CTLL cell death within 
24-48 h. Recent studies on murine TCGF have shown that:  (a)  T  cells are required 
for TCGF production, (b) only T-cell mitogens or antigens elicit TCGF production, 
and (c) only activated T cells absorb TCGF activity (14). These observations provide 
evidence that a specific TCGF acceptor molecule may exist on activated T  cells and 
that TCGF provides a second signal allowing for the expansion of antigen-activated 
T-cell clones. Although the immunochemical characterization of TCGF is unknown, 
a  similar B-cell second signal soluble factor  (the allogeneic effect factor)  has been 
shown to contain Ia gene region determinants (15).  Should TCGF be found to have 
a  similar  molecular constituency, a  TCGF  receptor  might  help  to  explain  the  Ia 
positive surface characterization of certain murine T-effector cell populations (16) and 
H-CTLL-1 cells (Table III). 
The fact that differentiated antigen-specific T cells can be maintained in continuous 
culture suggests that similar mechanisms may exist in vivo which operate to control 
the proliferation of differentiated effector T  cells. Investigators may therefore be able 
to utilize the in vitro system described here to study the regulation of several T-cell 
immune responses,  particularly through the  establishment of functional helper or 
suppressor  human  T-cell  lines.  This  approach  may provide  new  insight  into  the 
regulation of several immunopathological disease states. It is our belief that further 
study of differentiated T-cell lines and the effects that regulatory molecules (such as 
TCGF) mediate upon their reactivity will lead to important new discoveries regarding 
the mechanism of T-cell-mediated immunity. 
Summary 
Long-term cultures of human cytotoxie T-cell lines.(H-CTLL) were established. H- 
CTLL cells were strictly dependent for growth upon a T-cell growth factor (TCGF) 
produced by phytohemagglutinin-stimulated normal human peripheral  blood lym- 
phocytes. H-CTLL cells were maintained in TCGF-dependent exponential prolifer- 
1 p. E. Baker et al.  Manuscript submitted for publication. 
2 S. Gillis et al. Manuscript submitted for publication. 1098  GILLIS ET  AL.  BRIEF DEFINITIVE REPORT 
ative culture for over 4  mo during which time they continued to mediate stimulator 
antigen-specific cytotoxieity as measured  by a  4-h 51Cr-release assay. H-CTLL  cells 
recovered from cryopreserved stocks and re-established in long-term culture demon- 
strated similar high levels of antigen-specific cytotoxicity. H-CTLL cells were 95-100% 
E-rosette positive and expressed normal T  and Ia-like cell surface markers. The ability 
to  sustain  differentiated  antigen-specific T-effector  cells in  long-term  culture  may 
provide a  new means for the study of both the mechanism and regulation of T-cell- 
mediated immunity. 
The authors are very grateful to Ms. Linda Waidlich for her expert secretarial and editorial 
assistance. 
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